Founded in 2019 as the first site of Egin Research and acquired by Velocity Clinical Research in 2022, the experienced team at Velocity’s dedicated research site in High Wycombe conducts Phase 2-4 clinical trials across a broad variety of indications, including Infectious Disease, Pulmonology, Vaccines, and Women’s Health. By developing strong working relationships with local communities and having close ties with networks of cooperating practices, Velocity’s High Wycombe staff provides fast, accurate patient enrollment support, even for diverse populations.
Our High Wycombe team is committed to being a resource for study volunteers, to providing the highest quality of patient care with compassion and kindness and to advancing medicine through research. With decades of research experience shared among our investigators in High Wycombe, Velocity will deliver the right patients, investigators, and research staff for your next research program.
Now Enroling in High Wycombe
Velocity is enroling participants for clinical trials in High Wycombe for the following conditions:
- COPD
- Alopecia
- Fatty Liver or MASH (Formerly called NASH)